DrugInserts.com: Trustworthy FDA Drug Information

Vaccines and Other Medical Materials

Vaccines and Other Medical Materials Updated During 2011, From Oldest to Newest, Page 15

Page 15 of 20 « First Page 5 10 « 13 14 15 16 17 » 20 Last Page »

VARIVAX

Varicella Virus Vaccine Live

By Merck Sharp & Dohme Corp. | Last revised: 4 August 2011
VARIVAX

VARIVAX is indicated for vaccination against varicella in individuals 12 months of age and older. The duration of protection of VARIVAX is unknown; however, long-term efficacy studies have demonstrated continued protection up to 10 years after…

GLASSIA

Alpha-1-Proteinase Inhibitor (Human)

By Baxter Healthcare Corporation | Last revised: 12 August 2011
GLASSIA

Alpha-1-Proteinase Inhibitor (Human). GLASSIA is indicated for chronic augmentation and maintenance therapy in individuals with emphysema due to congenital deficiency of alpha 1 -proteinase inhibitor (Alpha 1 -PI), also known as alpha 1 -antitrypsin…

PENTACEL

DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE

By Sanofi Pasteur Inc. | Last revised: 17 August 2011
PENTACEL

Pentacel® is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use as a four dose series in children 6 weeks…

DAPTACEL

Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated), Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated), Bordetella Pertussis Toxoid Antigen (glutaraldehyde Inactivated), Bordetella Pertussis Filamentous Hemagglutinin Antigen (

By Sanofi Pasteur Inc. | Last revised: 17 August 2011
DAPTACEL

DAPTACEL® is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age (prior to seventh birthday). DAPTACEL is a vaccine indicated for active…

Treatment Set TS342034

Treatment Set TS342034

By Antigen Laboratories, Inc. | Last revised: 17 August 2011
Treatment Set TS342034

When the natural exposure to elevated aeroallergens produces symptoms as described under Clinical Pharmacology, specific diagnosis and therapeutic procedures are indicated. Clearly, important clues to the cause of a person’s allergic condition can…

Page 15 of 20 « First Page 5 10 « 13 14 15 16 17 » 20 Last Page »